-
AbbVie stands out as a dividend king, showcasing a positive outlook.
-
Enbridge provides a notably steady dividend.
-
Realty Income boasts a high dividend yield and promising growth prospects in Europe.
-
10 stocks we like better than AbbVie ›
The concept of passive income is appealing—just sit back and let the money flow in. Though, achieving that can be trickier than it sounds. Sometimes, investments that seem promising at first can lead to disappointing results later on.
That said, there are options that can provide steady and reliable income over time. If you’re looking for long-term passive income, here are three stocks worth considering.
When it comes to reliable dividend stocks, few groups are as elite as dividend kings. These are companies that have consistently increased dividends for at least 50 years. AbbVie, for instance, has raised its dividends for an impressive 53 consecutive years.
Currently, AbbVie’s future dividend yield is under 3%, which is at the lower end of its historical range. This makes sense, considering the pharmaceutical sector has seen significant growth recently, with gains exceeding 30% in 2025.
What’s driving AbbVie’s performance? The company adeptly navigated a potential disaster with the patent expiration of its blockbuster drug, Humira, in 2023. Thanks to investments in research and development, alongside strategic acquisitions, AbbVie is rolling out new products to lessen its reliance on Humira.
AbbVie’s prospects remain bright. The successors to Humira, Rinvoq and Skyrizi, are seeing skyrocketing sales, plus the company’s migraine medications Crypta and Ubrelvy are performing well. Additionally, AbbVie has around 50 programs in its pipeline that are in mid- to late-stage clinical trials, which bodes well for the future.
Moving on to Enbridge, while it may not be a dividend king, its history of dividend increases is quite noteworthy. This energy giant has upped its dividend every year for 30 years. As such, Enbridge qualifies as a Dividend Champion.
With a forthcoming dividend yield of 5.5%, investors can feel secure about this income. The company has sufficient free cash flow to comfortably meet its dividend obligations.
The nature of Enbridge’s operations lends further reliability to its dividends. It’s the largest natural gas utility in North America, moving about 20% of the natural gas consumed in the U.S. and 30% of total crude oil. Notably, around 80% of Enbridge’s EBITDA (earnings before interest, taxes, depreciation, and amortization) is insulated from inflation, and less than 1% is vulnerable to fluctuating commodity prices.
Looking ahead, Enbridge’s growth may not be explosive, but it doesn’t appear headed for a standstill either. The rise of data centers and the shift from coal to natural gas should support its growth potential.
Similarly, Realty Income has demonstrated a strong dividend history, having increased its dividends for 30 years. This real estate investment trust (REIT) also distributes payments monthly, which is a bit unique in the sector.
And here’s some good news: Realty Income boasts a forward dividend yield of 5.7%. High yields are typical for REITs since they must return 90% of their income as dividends to benefit from tax exemptions.
Investors searching for passive income will appreciate Realty Income’s consistency. The REIT has posted positive total operating income for 29 straight years, driven by a robust and diversified portfolio.
Moreover, Realty Income sees significant growth opportunities, especially in Europe, where the market is quite fragmented and valued at approximately $14 trillion.
Before diving into AbbVie stock, it’s worth noting that an analyst group has compiled a list of 10 stocks they believe could outperform AbbVie in the coming years. This isn’t to say AbbVie isn’t a solid choice; it just indicates there are other options to consider too.
So, if you’re pondering investments, take a look at these stocks. Who knows what potential they might hold?
